Dr. Kister is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
240 E 38th St
Fl 13
New York, NY 10016Phone+1 646-501-7500Fax+1 212-598-6214
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 2002 - 2006
Maimonides Medical CenterInternship, Internal Medicine, 2002 - 2003
Icahn School of Medicine at Mount SinaiClass of 2002
Certifications & Licensure
NY State Medical License 2006 - 2026
NJ State Medical License 2009 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients Start of enrollment: 2021 Jan 05
- Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA) Start of enrollment: 2021 Apr 20
- Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis Start of enrollment: 2020 Oct 26
Publications & Presentations
PubMed
- Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications.Carson M Quinn, Prashanth Rajarajan, Alexander J Gill, Hannah Kopinsky, Andrew B Wolf
Neurology. 2024-12-10 - Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination.Ilya Kister, Ryan Curtin, Amanda L Piquet, Tyler Borko, Jinglan Pei
Annals of Clinical and Translational Neurology. 2024-07-01 - 6 citationsDiagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid.Vyanka Redenbaugh, James P Fryer, Laura Cacciaguerra, John J Chen, Tammy M Greenwood
Annals of Neurology. 2024-07-01
Press Mentions
New (*48*) Confirms (*20*) on COVID Boosters in MSNovember 3rd, 2022- Severity of Multiple Sclerosis Symptoms Tied to Race/EthnicityJune 17th, 2021
Emerging MS Therapies, Advances in Stopping Progression and Restoring Function Among Themes of AAN MeetingMay 17th, 2019- Join now to see all
Professional Memberships
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
